Wire · opportunities
BlueWind Medical earns FDA clearance for next-gen tibial neuromod system
◆ Sectors
Medtech
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 31 August 2026 · Fusion42 review
BlueWind Medical received FDA 510(k) clearance for Revi Extend, its next-generation implantable tibial neuromodulation system for urgency urinary incontinence with an extended implant life of 15 years.
This Wire brief sits within Fusion42's coverage of Medtech.
◆ ◆ The Wire takeaway
Your implanted device just gained a longer lifespan under FDA rules. If you build or sell implantable neuromod devices, this raises the bar on durability customers will expect.
◆ Coverage
1 source · 5 Aug 2026
◆ Related on Wire
◆ Topics
Medtechfda-clearanceimplantable-deviceneuromodulationuuimedical-device